Pacifica Partners’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-400
| Closed | -$4.3K | – | 486 |
|
2024
Q3 | $4.3K | Hold |
400
| – | – | ﹤0.01% | 410 |
|
2024
Q2 | $4.8K | Hold |
400
| – | – | ﹤0.01% | 408 |
|
2024
Q1 | $5.95K | Hold |
400
| – | – | ﹤0.01% | 397 |
|
2023
Q4 | $6.16K | Hold |
400
| – | – | ﹤0.01% | 413 |
|
2023
Q3 | $7.78K | Hold |
400
| – | – | ﹤0.01% | 378 |
|
2023
Q2 | $8.96K | Hold |
400
| – | – | 0.01% | 312 |
|
2023
Q1 | $9.48K | Hold |
400
| – | – | 0.01% | 321 |
|
2022
Q4 | $5.28K | Hold |
400
| – | – | ﹤0.01% | 345 |
|
2022
Q3 | $5K | Hold |
400
| – | – | ﹤0.01% | 364 |
|
2022
Q2 | $4K | Hold |
400
| – | – | ﹤0.01% | 384 |
|
2022
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 351 |
|
2021
Q4 | $9K | Hold |
400
| – | – | 0.01% | 311 |
|
2021
Q3 | $18K | Hold |
400
| – | – | 0.01% | 233 |
|
2021
Q2 | $16K | Hold |
400
| – | – | 0.01% | 229 |
|
2021
Q1 | $21K | Buy |
+400
| New | +$21K | 0.02% | 196 |
|